Atrial fibrillation
Therapeutic area
Cardiology
Rare disease
No
- Definition
- A disorder characterized by an electrocardiographic finding of a supraventricular arrhythmia characterized by the replacement of consistent P waves by rapid oscillations or fibrillatory waves that vary in size, shape and timing and are accompanied by an irregular ventricular response. (CDISC)
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Atrial fibrillation
- Therapeutic area
- Cardiology
- atrial fibrillation
- AF
- AFib
- atrial fibrillation
- atrial fibrillation (disease)
- All therapeutic areas
- Cardiology
- Severity
- Severe
- MONDO ID
- MONDO:0004981
- Parent condition
- MONDO:0007263
Related records
Broader conditions (6)
- Cardiac rhythm disease
- Cardiovascular disorder
- Disease
- Disease by body system or component
- Heart disorder
- Human disease
Narrower conditions (21)
- Atrial fibrillation, familial, 1
- Atrial fibrillation, familial, 10
- Atrial fibrillation, familial, 11
- Atrial fibrillation, familial, 12
- Atrial fibrillation, familial, 13
- Atrial fibrillation, familial, 14
- Atrial fibrillation, familial, 15
- Atrial fibrillation, familial, 16
- Atrial fibrillation, familial, 17
- Atrial fibrillation, familial, 18
- Atrial fibrillation, familial, 2
- Atrial fibrillation, familial, 3
- Atrial fibrillation, familial, 4
- Atrial fibrillation, familial, 5
- Atrial fibrillation, familial, 6
- Atrial fibrillation, familial, 7
- Atrial fibrillation, familial, 8
- Atrial fibrillation, familial, 9
- Familial atrial fibrillation
- Paroxysmal atrial fibrillation
Trials (3,792)
- 'Understanding the Electrophysiological Substrate Underlying Persistent Atrial Fibrillation Study II (USURP AF- Study II)'
- "Atriogenic Tricuspid Selected, Omics Profile, Multimodality Imaging and Clinical Outcomes"
- "Cryptogenic Stroke and Atrial Fibrillation Detection Through Implantable Loop Recorder (ILR)"
- "De Novo" Atrial Fibrillation in Patients With Heart Failure: Incidence; Predictors and Relevance.
- "Info-AF" Information Preferences in Patients With Atrial Fibrillation/Flutter and the Association With Clinical Symptoms
- "UNMASKING Study" For Atrial Fibrillation Recurrences Typing in Early Postoperative Period
- 2-Hydroxybenzylamine (2-HOBA) to Prevent Early Recurrence of Atrial Fibrillation After Catheter-based Ablation
- 3-Dimensional Mapping System: The PULSTAR II Study
- 3-Dimensional Mapping System: The PULSTAR Study
- 30-Day Cardiac Event Monitor Belt for Recording Atrial Fibrillation After a Cerebral Ischemic Event
- 320-detector Computed Tomography to Assess Myocardial Extracellular Volume Fraction in Patients With Atrial Fibrillation Before AF Ablation.
- 3D Printing Technology For Planning Left Atrial Appendage Occlusion
- 3D-Guided Pulsed Field Ablation for Paroxysmal AF
- 7-day Holter Monitoring in Adult Patients With Recent IS or TIA, to Measure the Prevalence of Paroxysmal Atrial Fibrillation Including Episodes Less Than 30 Seconds: Transversal Study
- A Behavioural Weight Loss Intervention Delivered in Cardiac Rehabilitation for Patients With Atrial Fibrillation and Obesity
- A Blinded Study to Evaluate Effect on Atrial Fibrillation Burden in Patients With Paroxysmal Atrial Fibrillation
- A CALIBER Study: Risk Factors for Stroke, Heart Failure, and Myocardial Infarction in Atrial Fibrillation
- A Case Control Study to Investigate the Possible Association Between Atrial Fibrillation and Endothelium Dysfunction by Using Flow-Mediated Vasodilation Method
- A Clinical Study of the Arctic Front Cryoablation Balloon for the Treatment of Paroxysmal Atrial Fibrillation
- A Clinical Study on the Use of a Domestically Produced Cryoablation System Combined With Balloon Cryoablation Technology for the Treatment of Paroxysmal Atrial Fibrillation
Approved drugs (14)
- Apixaban
- Clopidogrel bisulfate
- Dabigatran etexilate mesylate
- Digoxin
- Diltiazem hydrochloride
- Dofetilide
- Dronedarone hydrochloride
- Edoxaban tosylate
- Heparin sodium
- Landiolol hydrochloride
- Propafenone hydrochloride
- Rivaroxaban
- Vernakalant hydrochloride
- Warfarin sodium
Drugs in development (122)
- 2-(aminomethyl)phenol Phase 2
- Abelacimab Phase 3
- Acenocoumarol Phase 3
- Acetylcysteine Phase 3
- Adenosine Phase 3
- Alcohol Phase 2
- Aliskiren Phase 3
- Amiodarone Phase 3
- Amiodarone hydrochloride Phase 3
- Ascorbic acid Phase 3
- Aspirin Phase 3
- Atecegatran metoxil Phase 2
- Atenolol Phase 3
- Atorvastatin Phase 3
- Avidin Phase 3
- AZD-2927 Phase 2
- AZD1305 Phase 2
- AZD7009 Phase 2
- Azimilide Phase 3
- Azimilide dihydrochloride Phase 3
Other linked drugs (10)
- Adenosine triphosphate
- Ajmaline
- Bucindolol
- Calcium
- Ibutilide
- Lidocaine
- Losartan
- Nebacumab
- Rituximab
- Sulamserod